Modeling Autistic Features in Animals
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index; none of the 129 sources its claims cite is checked for support yet.
Abstract
A variety of features of autism can be simulated in rodents, including the core behavioral hallmarks of stereotyped and repetitive behaviors, and deficits in social interaction and communication. Other behaviors frequently found in autism spectrum disorders (ASDs) such as neophobia, enhanced anxiety, abnormal pain sensitivity and eye blink conditioning, disturbed sleep patterns, seizures, and deficits in sensorimotor gating are also present in some of the animal models. Neuropathology and some characteristic neurochemical changes that are frequently seen in autism, and alterations in the immune status in the brain and periphery are also found in some of the models. Several known environmental risk factors for autism have been successfully established in rodents, including maternal infection and maternal valproate administration. Also under investigation are a number of mouse models based on genetic variants associated with autism or on syndromic disorders with autistic features. This review briefly summarizes recent developments in this field, highlighting models with face and/or construct validity, and noting the potential for investigation of pathogenesis, and early progress toward clinical testing of potential therapeutics. Wherever possible, reference is made to reviews rather than to primary articles.
Overview
CoChat Summary
TL;DR
This review argues that several rodent models—especially maternal infection/immune activation and maternal valproate, plus selected genetic models—reproduce core autism-like behavioral features and some neuropathology, with face and/or construct validity. It highlights preclinical therapeutic leads but notes major obstacles, including the lack of biomarkers and the difficulty of modeling social and communication deficits in rodents.
Key findings
- Environmental risk-factor models show autism-like phenotypes: maternal infection/MIA with poly(I:C) or LPS and maternal valproic acid produce offspring with deficits in social interaction and communication, increased repetitive/stereotyped behaviors, anxiety, neophobia, impaired prepulse inhibition, and in some cases Purkinje-cell deficits. A Danish register study of over 10,000 autism cases found a significant association with maternal viral infection in the first trimester.
- Genetic models provide construct and variable face validity: Fmr1 KO mice show impaired social interaction and repetitive behavior, and a 50% reduction of mGluR5 normalizes dendrite morphology, seizure susceptibility, and inhibitory avoidance extinction; MeCP2 mutant female mice appear normal until about 16 weeks of age, and restoring MeCP2 reverses disease phenotype; Tsc2+/− mice show a social interaction deficit only when born to poly(I:C)-treated mothers; NLGN-4 KO mice show abnormal reciprocal social interaction and impaired ultrasonic vocalization communication but not repetitive behavior.
- Several interventions ameliorate model phenotypes: N-acetyl-cysteine, anti-IL-6 antibody, IL-10, pioglitazone, environmental enrichment, rapamycin, IGF-1, and D-cycloserine are discussed as preclinical or early clinical leads. Environmental enrichment for one week in VPA offspring improved anxiety, stereotyped behaviors, social interaction, and PPI, with effects lasting through adulthood.
- BTBR mice show low sociability, high spontaneous repetitive grooming, poor reversal learning, more and longer pup ultrasonic vocalizations, exaggerated stress responses with high corticosterone, and absence of the corpus callosum; however, comparisons are complicated because they are made to unrelated mouse strains.
Methods
- Narrative review of animal models of autistic features, emphasizing models with face and/or construct validity and potential for pathogenesis and therapeutic testing; the author states that references are made to reviews rather than primary articles wherever possible.
- Covers rodent models based on environmental risk factors (maternal infection, maternal immune activation with poly(I:C) or LPS, maternal valproic acid) and genetic variants/syndromic disorders (FMR1, MeCP2, TSC, NLGN3/4, CNTNAP2, OT/AVP, BTBR), with brief mention of non-human primate models.
- No primary experiments, systematic search, or meta-analysis are described.
Limitations
- The paper states that autism is defined by core behavioral abnormalities rather than objective biomarkers; social interaction and communication can only be approximated in rodents; autism may represent behaviorally distinct disorders with different causes and pathogenesis; genetics is complex; and there is no pathognomonic feature to distinguish, for example, an “autistic mouse” from a “schizophrenic mouse.”
- Evident from the text: many cited findings are described as unpublished data; some models have mixed face validity (e.g., OT and V1aR KO mice show reduced anxiety-like behavior, which is inconsistent with autism); BTBR comparisons to unrelated strains are problematic; species differences for OT/AVP are striking; and neuropathology, immune status, gastrointestinal status, and the male bias remain understudied.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 94 Not checked · 31 Own results and interpretations
In the paper
“two of the core features, deficits in social interaction and in communication, can only be approximated in rodent studies (1).”
§ Modeling Autistic Features in Animals > Abstract
What the sources say
- Not checked yetcites [1] Silverman JL Yong M Lord C Crawley JN 2010 Behavioral phenotyping assays for mouse models of autism Nat Rev Neurosci 11 490 502 20559336 PMC3087436
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“An examination of over 10,000 autism cases found a very significant association with maternal viral infection in the first trimester (5).”
§ Modeling Autistic Features in Animals > Environmental risk factors > Maternal infection
What the sources say
- Not checked yetcites [5] Atladóttir HO Thorsen P Østergaard L Schendel DE Lemcke S Abdallah M Parner ET 2010 Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders J Autism Dev Disord 40 1423 1430 20414802
boostedstates an associationn = 10,000- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A variety of features of autism can be simulated in rodents, including the core behavioral hallmarks of stereotyped and repetitive behaviors, and deficits in social interaction and communication.”
§ Modeling Autistic Features in Animals > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A very large epidemiological study utilizing the Danish Medical Register recently confirmed and strongly extended prior studies that suggested maternal infection as a risk factor for autism in the offspring.”
§ Modeling Autistic Features in Animals > Environmental risk factors > Maternal infection
What the sources say
- Not checked yetcites [5] Atladóttir HO Thorsen P Østergaard L Schendel DE Lemcke S Abdallah M Parner ET 2010 Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders J Autism Dev Disord 40 1423 1430 20414802
boostedstates an associationn = 10,000- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent electrophysiological studies have revealed synaptic changes within the hippocampus and in its communication with the prefrontal cortex (12–14).”
§ Modeling Autistic Features in Animals > Environmental risk factors > Maternal infection
What the sources say
- Not checked yetcites [12] Ito HT Smith SE Hsiao E Patterson PH 2010 Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring Brain Behav Immun 24 930 941 20227486 PMC2897971
- Not checked yetcites [13] Dickerson DD Wolff AR Bilkey DK 2010 Abnormal long-range neural synchrony in a maternal immune activation animal model of schizophrenia J Neurosci 30 12424 12431 20844137 PMC6633437
- Not checked yetcites [14] Oh-Nishi A Obayashi S Sugihara I Suhara T 2010 Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring Brain Res 1363 170 179 20863817
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
63 more claims
Create a free account to see all 125 claims and to verify the 129 references still open.
- It may state two separate claims as one. 46
- Probably not a substantial claim. 12
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Modeling Autistic Features in Animals > Genetic models > MeCP2
“Synaptic dysfunction can also be achieved by increasing the level of another growth factor, brain-derived neurotrophic factor(39).”
§ Modeling Autistic Features in Animals > References
“39. Kline DD Ogier M Kuze DL Katz DM 2010 Exogenous brain-derived neurotrophic factor rescues synaptic dysfunction in Mecp2-null mice J Neurosci 30 5303 5310 20392952 PMC3367888”
Citations
Cites
Neuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849 · cited 1×
“Mutations in neurexin and SHANK3 are also found in ASD probands, but whether they are involved in ASD etiology is controversial (47).”
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2178-07.2007 · Cited by 1,605
Self-citationThe mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580 · cited 6×
“Abbreviations: ASD, autism spectrum disorders; CNTNAP2, contactinassociated protein-like 2; EE, environmental enrichment; FXS, Fragile X syndrome; LPS, lipopolysaccharide; MeCP2, methyl-CpG-binding protein; MIA, maternal immune activation; mTOR, mammalian target of rapamycin; NLGN, neuroligin; OT, oxytocin; poly(I:C),…”
InfluentialAmaral, D. G., Schumann, C. M., & Nordahl, C. W. (2008) · Trends in Neurosciences · doi:10.1016/j.tins.2007.12.005 · Cited by 1,492
Behavioural phenotyping assays for mouse models of autism
Silverman, J. L., Yang, M., Lord, C., & Crawley, J. N. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2851 · Cited by 1,462 · cited 10×
“Such a deficit is reported in adult BTBR mice (1).”
InfluentialPrenatal Infection and Schizophrenia: A Review of Epidemiologic and Translational Studies
Brown, A. S., & Derkits, E. J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030361 · Cited by 1,269
The Story of Rett Syndrome: From Clinic to Neurobiology
Chahrour, M., & Zoghbi, H. Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.10.001 · Cited by 1,265 · cited 10×
“Abbreviations: ASD, autism spectrum disorders; CNTNAP2, contactinassociated protein-like 2; EE, environmental enrichment; FXS, Fragile X syndrome; LPS, lipopolysaccharide; MeCP2, methyl-CpG-binding protein; MIA, maternal immune activation; mTOR, mammalian target of rapamycin; NLGN, neuroligin; OT, oxytocin; poly(I:C),…”
InfluentialInsel, T. R. (2010) · Neuron · doi:10.1016/j.neuron.2010.03.005 · Cited by 1,044
A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice
Tabuchi, K., Blundell, J., Etherton, M. R., Hammer, R. E., Liu, X., Powell, C. M., & Südhof, T. C. (2007) · Science · doi:10.1126/science.1146221 · Cited by 997
Maternal Infection Requiring Hospitalization During Pregnancy and Autism Spectrum Disorders
Atladóttir, H. Ó., Thorsen, P., Østergaard, L., Schendel, D. E., Lemcke, S., Abdallah, M., & Parner, E. T. (2010) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-010-1006-y · Cited by 916 · cited 1×
“An examination of more than 10,000 autism cases found a significant association with maternal viral infection in the first trimester (5).”
Research works printed but not linked: 1
- Patterson PH 2011 Brain-Immune Dialogues and what they mean for autism, schizophrenia and depression MIT Press Cambridge, MA in press
Cited by
Neocortical excitation/inhibition balance in information processing and social dysfunction
Yizhar, O., Fenno, L. E., Prigge, M., Schneider, F., Davidson, T. J., O’Shea, D. J., Sohal, V. S., Goshen, I., Finkelstein, J., Paz, J. T., et al. (2011) · Nature · doi:10.1038/nature10360 · Cited by 2,454
Malkova, N. V., Yu, C. Z., Hsiao, E. Y., Moore, M. J., & Patterson, P. H. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.01.011 · Cited by 662
“S1) that we have seen in single-injected mothers and influenza-infected mothers (Shi et al., 2003; Smith et al., 2007; Hsiao and Patterson, 2011).”
BackgroundSelf-citationRodent models in neuroscience research: is it a rat race?
Ellenbroek, B., & Youn, J. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.026120 · Cited by 627
“Several rat models for ASD have been developed recently, primarily based on environmental manipulations such as maternal immune activation or prenatal exposure to valproate (Patterson, 2011).”
BackgroundEpilepsy and brain inflammation
Vezzani, A., Aronica, E., Mazarati, A., & Pittman, Q. J. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.033 · Cited by 603
Immune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Garay, P. A., Hsiao, E. Y., Patterson, P. H., & McAllister, A. K. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.07.008 · Cited by 366
“…SZ and ASD in offspring (Brown and Derkits, 2010; Brown and Patterson, 2011; Patterson, 2011a), and maternal viral infection is associated with increased risk of ASD as well as a 3–7-fold increased risk of SZ in the offspring (Atladottir et al., 2010; Brown et al., 2004; Brown and Patterson, 2011).”
InfluentialSelf-citationMaternal immune activation and autism spectrum disorder: From rodents to nonhuman and human primates
Careaga, M., Murai, T., & Bauman, M. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.10.020 · Cited by 348
Cross talk: the microbiota and neurodevelopmental disorders
Kelly, J. R., Minuto, C., Cryan, J. F., Clarke, G., & Dinan, T. G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00490 · Cited by 271
Gastrointestinal Conditions in Children With Autism Spectrum Disorder: Developing a Research Agenda
Coury, D. L., Ashwood, P., Fasano, A., Fuchs, G., Geraghty, M., Kaul, A., Mawe, G., Patterson, P., & Jones, N. E. (2012) · Pediatrics · doi:10.1542/peds.2012-0900n · Cited by 264
Self-citationExploring the Validity of Valproic Acid Animal Model of Autism
Mabunga, D. F. N., Gonzales, E. L. T., Kim, J.-W., Kim, K. C., & Shin, C. Y. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.4.285 · Cited by 247
Wang, L., Wang, B., Wu, C., Wang, J., & Sun, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031819 · Cited by 237
Oxidative Stress and Immune System Dysfunction in Autism Spectrum Disorders
Pangrazzi, L., Balasco, L., & Bozzi, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093293 · Cited by 218
“These include maternal respiratory infection with influenza virus and maternal immune activation (MIA) with either polyinosine:cytosine (poly(I:C), a synthetic, double-stranded RNA that evokes an antiviral-like immune reaction) or lipopolysaccharide (LPS), which evokes an antibacterial-like immune reaction [65].”
BackgroundGastrointestinal issues in autism spectrum disorder
Hsiao, E. Y. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000029 · Cited by 209
Ketogenic Diet Improves Core Symptoms of Autism in BTBR Mice
Ruskin, D. N., Svedova, J., Cote, J. L., Sandau, U., Rho, J. M., Kawamura, M., Boison, D., & Masino, S. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065021 · Cited by 173
“We found that the KD improved all three behavioral deficits significantly [16], and, in contrast to other models of autism [17,18] the BTBR mouse does not exhibit spontaneous behavioral or electrographic seizures.”
ResultAntipurinergic Therapy Corrects the Autism-Like Features in the Poly(IC) Mouse Model
Naviaux, R. K., Zolkipli, Z., Wang, L., Nakayama, T., Naviaux, J. C., Le, T. P., Schuchbauer, M. A., Rogac, M., Tang, Q., Dugan, L. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057380 · Cited by 171
Translational Mouse Models of Autism: Advancing Toward Pharmacological Therapeutics
Kazdoba, T. M., Leach, P. T., Yang, M., Silverman, J. L., Solomon, M., & Crawley, J. N. (2015) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2015_5003 · Cited by 170
Advances in understanding the pathophysiology of autism spectrum disorders
Yenkoyan, K. B., Grigoryan, A., Fereshetyan, K., & Yepremyan, D. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.038 · Cited by 169
The Endocannabinoid System and Autism Spectrum Disorders: Insights from Animal Models
Zamberletti, E., Gabaglio, M., & Parolaro, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091916 · Cited by 126
Microglia in the pathogenesis of autism spectrum disorders
Koyama, R., & Ikegaya, Y. (2015) · Neuroscience Research · doi:10.1016/j.neures.2015.06.005 · Cited by 160
Wilson, C., & Koenig, J. I. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.008 · Cited by 158
Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment?
Gładysz, D., Krzywdzińska, A., & Hozyasz, K. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0822-x · Cited by 127
Scattoni, M. L., Martire, A., Cartocci, G., Ferrante, A., & Ricceri, L. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.028 · Cited by 128
Al-Amin, M. M., Rahman, M., Khan, F. R., Zaman, F., & Reza, H. M. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.02.041 · Cited by 141
Naviaux, J. C., Schuchbauer, M. A., Li, K., Wang, L., Risbrough, V. B., Powell, S. B., & Naviaux, R. K. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.33 · Cited by 134
Veenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128
“Patterson PH (2011). Modeling autistic features in animals.”
BackgroundIncreased BDNF expression in fetal brain in the valproic acid model of autism
Almeida, L. E. F., Roby, C. D., & Krueger, B. K. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.01.007 · Cited by 97
Pratt, K. G., & Khakhalin, A. S. (2013) · Disease Models & Mechanisms · doi:10.1242/dmm.012138 · Cited by 115
Harvey, L., & Boksa, P. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.11.022 · Cited by 105
Mitochondrial Dysfunction in Autism
Legido, A., Jethva, R., & Goldenthal, M. J. (2013) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2013.10.008 · Cited by 104
P-cresol Alters Brain Dopamine Metabolism and Exacerbates Autism-Like Behaviors in the BTBR Mouse
Pascucci, T., Colamartino, M., Fiori, E., Sacco, R., Coviello, A., Ventura, R., Puglisi-Allegra, S., Turriziani, L., & Persico, A. M. (2020) · Brain Sciences · doi:10.3390/brainsci10040233 · Cited by 92
Toward an immune-mediated subtype of autism spectrum disorder
McDougle, C. J., Landino, S. M., Vahabzadeh, A., O’Rourke, J., Zurcher, N. R., Finger, B. C., Palumbo, M. L., Helt, J., Mullett, J. E., Hooker, J. M., et al. (2015) · Brain Research · doi:10.1016/j.brainres.2014.09.048 · Cited by 95
Wu, W.-L., Adams, C. E., Stevens, K. E., Chow, K.-H., Freedman, R., & Patterson, P. H. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.02.005 · Cited by 85
Self-citationHäring, M., Kaiser, N., Monory, K., & Lutz, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026617 · Cited by 74
Natural Antioxidants: A Novel Therapeutic Approach to Autism Spectrum Disorders?
Pangrazzi, L., Balasco, L., & Bozzi, Y. (2020) · Antioxidants · doi:10.3390/antiox9121186 · Cited by 82
Optogenetic Insights into Social Behavior Function
Yizhar, O. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.029 · Cited by 81
Advances in nonhuman primate models of autism: Integrating neuroscience and behavior
Bauman, M. D., & Schumann, C. M. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.07.021 · Cited by 80
Belinson, H., Nakatani, J., Babineau, B. A., Birnbaum, R. Y., Ellegood, J., Bershteyn, M., McEvilly, R. J., Long, J. M., Willert, K., Klein, O. D., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.207 · Cited by 79
“Several known environmental exposure models, including maternal infection and maternal valproate administration, have emphasized the importance of this embryonic period 65, 66 .”
Modeling autism-relevant behavioral phenotypes in rats and mice: Do ‘autistic’ rodents exist?
Servadio, M., Vanderschuren, L. J. M. J., & Trezza, V. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000163 · Cited by 76
“For instance, injection of poly I:C on gestational day 9.5 or 12.5 caused impairments in social interaction and anxiety behaviors in the offspring (Shi et al. , 2003; Smith et al. , 2007; Hsiao and Patterson, 2011), together with altered cerebellar development (Shi et al. , 2009).”
InfluentialRomero, R. J., Chaemsaithong, P., Docheva, N., Korzeniewski, S. J., Tarca, A. L., Bhatti, G., Xu, Z., Kusanovic, J. P., Chaiyasit, N., Dong, Z., et al. (2015) · Journal of Perinatal Medicine · doi:10.1515/jpm-2015-0121 · Cited by 75
Grimsley, J. M. S., Hazlett, E., & Wenstrup, J. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2205-13.2013 · Cited by 71
Scott, K. E., Kazazian, K., Mann, R. S., Möhrle, D., Schormans, A. L., Schmid, S., & Allman, B. L. (2020) · Autism Research · doi:10.1002/aur.2364 · Cited by 68
The major histocompatibility complex and autism spectrum disorder
Needleman, L. A., & McAllister, A. K. (2012) · Developmental Neurobiology · doi:10.1002/dneu.22046 · Cited by 66
Sultan, F. A., & Sweatt, J. D. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-8289-5_6 · Cited by 67
Chao, O. Y.-H., Pathak, S. S., Zhang, H., Dunaway, N., Li, J., Mattern, C., Nikolaus, S., Huston, J. P., & Yang, Y. (2020) · Molecular Brain · doi:10.1186/s13041-020-00649-7 · Cited by 66
Seese, R. R., Maske, A. R., LYNCH, G. S., & Gall, C. M. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.13 · Cited by 65
Fereshetyan, K., Chavushyan, V. A., Danielyan, M., & Yenkoyan, K. B. (2021) · Scientific Reports · doi:10.1038/s41598-021-02994-6 · Cited by 64
Malformation of the superior olivary complex in an animal model of autism
Lukose, R., Schmidt, E., Wolski, T. P., Murawski, N. J., & Kulesza, R. J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.013 · Cited by 59
Díaz-Caneja, C., State, M., Hagerman, R., Jacquemont, S., Marín, O., Bagni, C., Umbricht, D., Simonoff, E., de Andrés-Trelles, F., Kaale, A., et al. (2021) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.02.020 · Cited by 55
Aavani, T., Rana, S. A., Hawkes, R. B., & Pittman, Q. J. (2015) · The Cerebellum · doi:10.1007/s12311-015-0669-5 · Cited by 60
Mutant Mouse Models of Autism Spectrum Disorders
Provenzano, G., Zunino, G., Genovesi, S., Sgadó, P., & Bozzi, Y. (2012) · Disease Markers · doi:10.1155/2012/916082 · Cited by 60
Naik, A. A., Patro, I. K., & Patro, N. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00446 · Cited by 58
Adıgüzel, E., Çiçek, B., Ünal, G., Aydın, M. F., & Keti, D. B. (2022) · Physiology & Behavior · doi:10.1016/j.physbeh.2022.113961 · Cited by 56
Topál, J., Román, V., & Turcsán, B. (2019) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1495 · Cited by 52
Faraji, J., Karimi, M., Lawrence, C., Mohajerani, M. H., & Metz, G. A. S. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0280-x · Cited by 49
Gadad, B. S., Li, W., Yazdani, U., Grady, S., Johnson, T., Hammond, J., Gunn, H. C., Curtis, B., English, C. N., Yutuc, V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500968112 · Cited by 46
Perinatal Influences of Valproate on Brain and Behaviour: An Animal Model for Autism
Ranger, P., & Ellenbroek, B. A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_404 · Cited by 46
Pobbe, R. L. H., Pearson, B. L., Blanchard, D. C., & Blanchard, R. J. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.02.024 · Cited by 40
Hirsch, M. M., Deckmann, I., Santos‐Terra, J., Staevie, G. Z., Fontes‐Dutra, M., Carello‐Collar, G., Rockenbach, M. K., Schwingel, G. B., Bauer‐Negrini, G., Rabelo, B. F., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107930 · Cited by 41
Breach, M. R., Dye, C. N., Joshi, A., Platko, S., Gilfarb, R. A., Krug, A. R., Franceschelli, D. V., Galan, A., Dodson, C. M., & Lenz, K. M. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.03.025 · Cited by 41
Impact of prenatal environmental stress on cortical development
Ishii, S., & Hashimoto‐Torii, K. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00207 · Cited by 40
Daghestani, M. H., Selim, M. E., Abd‐Elhakim, Y. M., Said, E. N., El-Hameed, N. E. A., Khalil, S. R., & El-Tawil, O. S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.06.034 · Cited by 39
Giulivi, C., Napoli, E., Schwartzer, J. J., Careaga, M., & Ashwood, P. (2013) · Mediators of Inflammation · doi:10.1155/2013/609602 · Cited by 38
Experimental Models to Study Autism Spectrum Disorders: hiPSCs, Rodents and Zebrafish
Pensado‐López, A., Veiga-Rúa, S., Carracedo, Á., Allegue, C., & Sanchez, L. E. (2020) · Genes · doi:10.3390/genes11111376 · Cited by 36
Stereotypies in the Autism Spectrum Disorder: Can We Rely on an Ethological Model?
Keller, R., Costa, T., Imperiale, D., Bianco, A., Rondini, E., Hassiotis, A., & Bertelli, M. O. (2021) · Brain Sciences · doi:10.3390/brainsci11060762 · Cited by 36
Bercum, F. M., Rodgers, K. M., Benison, A. M., Smith, Z. Z., Taylor, J. A., Brunsgaard, E. K., Grabenstatter, H. L., Dudek, F. E., & Barth, D. S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2803-15.2015 · Cited by 36
Abnormal repetitive behaviors in zebrafish and their relevance to human brain disorders
Zabegalov, K. N., Khatsko, S. L., Lakstygal, A. M., Demin, K. A., Cleal, M., Fontana, B. D., McBride, S. D., Harvey, B. H., de Abreu, M. S., Parker, M. O., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.03.044 · Cited by 36
Cosín‐Tomás, M., Luan, Y., Leclerc, D., Malysheva, O., Lauzon, N., Bahous, R. H., Christensen, K. E., Caudill, M. A., & Rozen, R. R. (2020) · Nutrients · doi:10.3390/nu12061716 · Cited by 35
Gunn, R. K., Huentelman, M. J., & Brown, R. E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.07.008 · Cited by 34
Autism Spectrum Disorders: Autonomic Alterations with a Special Focus on the Heart
Ellenbroek, B. A., & Sengul, H. K. (2017) · Heart and Mind · doi:10.4103/hm.hm_5_17 · Cited by 33
Adolescent behavioral abnormalities in a Scn1a+/− mouse model of Dravet syndrome
Bahceci, D., Anderson, L. L., Brown, C., Zhou, C., & Arnold, J. C. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106842 · Cited by 33
Mehra, S., Ahsan, A. U., Seth, E., & Chopra, M. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02033-7 · Cited by 33
Functional Enrichment Analysis with Structural Variants: Pitfalls and Strategies
Webber, C. (2011) · Cytogenetic and Genome Research · doi:10.1159/000331670 · Cited by 33
Quantitative mouse brain phenotyping based on single and multispectral MR protocols
Badea, A., Gewalt, S., Avants, B. B., Cook, J. J., & Johnson, G. A. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.07.021 · Cited by 32
Animal Models of Psychiatric Disorders That Reflect Human Copy Number Variation
Nomura, J., & Takumi, T. (2012) · Neural Plasticity · doi:10.1155/2012/589524 · Cited by 32
Brain in flames – animal models of psychosis: utility and limitations
Wolf, S. A., Mattei, D., & Schweibold, R. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s65564 · Cited by 31
The Pathophysiological Link Between Reelin and Autism: Overview and New Insights
Scala, M., Grasso, E. A., Cara, G. D., Riva, A., Striano, P., & Verrottı, A. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.869002 · Cited by 29
Altered Caecal Neuroimmune Interactions in the Neuroligin-3R451C Mouse Model of Autism
Sharna, S. S., Balasuriya, G. K., Hosie, S., Nithianantharajah, J., Franks, A. E., & Hill‐Yardin, E. L. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00085 · Cited by 29
Zolkipli‐Cunningham, Z., Naviaux, J. C., Nakayama, T., Hirsch, C. M., Monk, J. M., Li, K., Wang, L., Le, T. P., Meinardi, S., Blake, D. R., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0248771 · Cited by 27
Altered nociceptive behavior and emotional contagion of pain in mouse models of autism
Martin, L. J., Poulson, S. J., Mannan, E., Sivaselvachandran, S., Cho, M., Setak, F., & Chan, C. (2021) · Genes Brain & Behavior · doi:10.1111/gbb.12778 · Cited by 26
Brain Autoantibodies in Autism Spectrum Disorder
Elamin, N. E., & AL-Ayadhi, L. Y. (2014) · Biomarkers in Medicine · doi:10.2217/bmm.14.1 · Cited by 26
Eleiwa, N. Z. H., Elsayed, A., Said, E. N., Metwally, M. M. M., & Abd‐Elhakim, Y. M. (2023) · Food and Chemical Toxicology · doi:10.1016/j.fct.2023.114372 · Cited by 25
Seyedinia, S. A., Tarahomi, P., Abbarin, D., Sedaghat, K., Rashidy‐Pour, A., Yaribeygi, H., Vafaei, A. A., & Raise‐Abdullahi, P. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01275-7 · Cited by 23
de Bruin, N. M. W. J., van Loevezijn, A., Wicke, K. M., de Haan, M., Venhorst, J., Lange, J. H. M., de Groote, L., van der Neut, M. A. W., Prickaerts, J., Andriambeloson, E., et al. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.06.020 · Cited by 22
“…with SLV at a dose of 30 mg/kg p.o. Offspring of VPA-exposed animals exhibit an array of developmental and behavioral deficits corresponding to those observed in autism and potentially schizophrenia (Ingram et al., 2000; Patterson, 2011; Schneider & Przewłocki, 2005; Schneider et al., 2008).”
BackgroundInfluentialMehra, S., Ahsan, A. U., Sharma, M., Budhwar, M., & Chopra, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03826-6 · Cited by 22
Peralta, F. A., Fuentealba, C., Fiedler, J. L., & Aliaga, E. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5529 · Cited by 22
Novais, A. R. B., Guiramand, J., Cohen‐Solal, C., Crouzin, N., Ferreira, M. D. J., Vignes, M., Barbanel, G., & Cambonie, G. (2013) · Pediatric Research · doi:10.1038/pr.2013.40 · Cited by 22
Deficits in temporal processing in mice prenatally exposed to Valproic Acid
Acosta, J., Campolongo, M., Höcht, C., Depino, A. M., Golombek, D. A., & Agostino, P. V. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13621 · Cited by 22
Möhrle, D., Yuen, M., Zheng, A., Haddad, F. L., Allman, B. L., & Schmid, S. (2023) · Genes Brain & Behavior · doi:10.1111/gbb.12841 · Cited by 21
Bové, M., Schiavone, S., Tucci, P., Sikora, V., Dimonte, S., Colia, A. L., Morgese, M. G., & Trabace, L. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110560 · Cited by 21
A Songbird Animal Model for Dissecting the Genetic Bases of Autism Spectrum Disorder
Panaitof, S. C. (2012) · Disease Markers · doi:10.1155/2012/727058 · Cited by 22
Tang, Y., Illes, P., Zhang, Y., Yin, H.-Y., & Rubini, P. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220302152400 · Cited by 20
Astroglial control of neuroinflammation: TLR3-mediated dsRNA-sensing pathways are in the focus
Salmina, A. B., Komleva, Y. K., Lopatina, O. L., Kuvacheva, N. V., Gorina, Y. V., Panina, Y. A., Uspenskaya, Y. A., Petrova, M. M., Demko, I. V., Zamay, A. S., et al. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0052 · Cited by 19
The Microbiome–Genetics Axis in Autism Spectrum Disorders: A Probiotic Perspective
Mihailovich, M., Tolinački, M., Bajić, S. S., Leštarević, S., Pejovic-Milovancevic, M., & Golić, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212407 · Cited by 20
Understanding the behavioural phenotype of the precocial spiny mouse
Ratnayake, U., Quinn, T., Daruwalla, K. D., Dickinson, H., & Walker, D. W. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.08.035 · Cited by 19
Zeid, E. H. A., Khalifa, B. A., Elewa, Y. H. A., Arisha, A. H., Ismail, T. A., Hendam, B. M., & Abdel-Hamid, S. E. (2021) · Food and Chemical Toxicology · doi:10.1016/j.fct.2021.112309 · Cited by 18
Mouse Behavior and Models for Autism Spectrum Disorders
Ricceri, L., Michetti, C., & Scattoni, M. L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800109-7.00017-0 · Cited by 17
Disruption of visual circuit formation and refinement in a mouse model of autism
Cheng, N., Khanbabaei, M., Murari, K., & Rho, J. M. (2016) · Autism Research · doi:10.1002/aur.1687 · Cited by 17
Harper, L., Choleris, E., Ervin, K. S. J., Fureix, C., Reynold, K., WALKER, M. D., & Mason, G. J. (2015) · Animal Welfare · doi:10.7120/09627286.24.4.463 · Cited by 17
Medhi, B., Ruhela, R. K., Sarma, P., Soni, S., & Prakash, A. (2017) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_183_17 · Cited by 16
Durankuş, F., Albayrak, Y., Erdoğan, F., Albayrak, N., Erdoğan, M. A., & Erbaş, O. (2022) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10221 · Cited by 16
Metadata
- Authors
- PATTERSON, P. H.
- Affiliations
- California Institute of Technology (US)
- Corresponding author
- PATTERSON, PAUL H.
- ORCID
- PATTERSON, PAUL H.
- Venue
- Pediatric Research
- Published
- 2011-05
- Volume
- 69
- Issue
- 5 Part 2
- Pages
- 34R-40R
- ISSN
- 0031-3998 (ISSN-L)
- PMC
- PMC3088489
- OpenAlex
- W2118279984
- Cited by
- 188
- References
- 63
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 6 · 2023: 14 · 2022: 9 · 2021: 16 · 2020: 16 · 2019: 5 · 2018: 6 · 2017: 10 · 2016: 11 · 2015: 23 · 2014: 16 · 2013: 11 · 2012: 24
- FWCI
- 1.44
- Type
- journal article
- Language
- en
- Open access
- green
- pmc.ncbi.nlm.nih.gov
- Locations
- Pediatric Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- Funders
- Autism Speaks (AS1606)
- National Institute of Mental Health (P50MH086383, R01MH086781, R01MH088879, R01MH079299)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- autism spectrum disorder, animal models of autism, rodent models, social interaction deficits, neophobia, anxiety, pain sensitivity, eyeblink conditioning, sleep disorders, seizures, sensorimotor gating, neuropathology, neurochemistry, immunological changes, environmental risk factors, maternal infection, genetic mouse models, syndromic disorders, face validity, construct validity, autism pathogenesis
- MeSH terms
- Animals, Autistic Disorder, Disease Models, Animal, Humans, Risk Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.